BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 18, 2013
View Archived Issues
Inflection Biosciences and CNIO present novel dual PIM/PI3K and triple PIM/PI3K/mTOR inhibitors
Read More
Oxygen Biotherapeutics closes acquisition of Phyxius Pharma's levosimendan
Read More
UCI-50027 as a promising neuroactive steroid showing anticonvulsant and anxiolytic activity in vivo
Read More
Roche reports on discovery of a novel, direct-acting, RNA polymerase enzyme inhibitor to target HCV
Read More
Xofigo obtains marketing authorization in the E.U.
Read More
Ajinomoto patents novel integrin alpha4beta7 receptor antagonists
Read More
Toray Industries divulges novel soluble epoxide hydrolase inhibitors
Read More
Toyama Chemical scientists prepare and test deuterated antiviral agents
Read More
Yale University reports discovery of cytotoxic-drug-delivering molecules for HIV
Read More
Trk-A inhibitors reported in Ono Pharmaceutical patent
Read More
Global Genomics and Metabolon partner to discover cardiovascular disease biomarkers and drug targets
Read More
Cepheid presents early data for Xpert HPV test
Read More
FDA grants orphan drug designation to Epidiolex for Dravet syndrome
Read More
Baxter and Cell Therapeutics enter licensing agreement for pacritinib
Read More
ChanRx presents promising data from the COR-ART phase II trial
Read More
French ATU granted for Vimizim in Morquio A syndrome
Read More
Eisai forms partnership to make Halaven available in the Middle East
Read More
A novel KIT gene mutation identified in papillary thyroid carcinoma
Read More
Sanofi discontinues development of fedratinib over safety concerns
Read More
Akorn acquires U.S. rights to three ophthalmic products from Merck & Co.
Read More
BARDA exercises option for continued development of AverTox against nerve agents
Read More
FDA approves Valeant's Luzu for three fungal indications
Read More
Bayer, Inception Sciences and Versant Ventures establish ophthalmology collaboration
Read More
Tolerability and immunogenicity of the live attenuated tetravalent dengue vaccine candidate TV-003
Read More
Phase Ib trial for ATU-027 planned in head and neck squamous cell carcinoma
Read More